Martin Falk

Executive Medical Director, Oncology at CureVac AG - Boston, MA, US

Martin Falk's Colleagues at CureVac AG
Paula Muresan

Scientist, Product Design and Formulation

Contact Paula Muresan

Lipika Sahu

IT Automation Specialist

Contact Lipika Sahu

Alba Infantes

Process Development USP Scientist

Contact Alba Infantes

Miriam Vogel

Associate Director Intellectual Property

Contact Miriam Vogel

View All Martin Falk's Colleagues
Martin Falk's Contact Details
HQ
617-377-4040
Location
Frankfurt,Hesse,Germany
Company
CureVac AG
Martin Falk's Company Details
CureVac AG logo, CureVac AG contact details

CureVac AG

Boston, MA, US • 250 - 499 Employees
BioTech/Drugs

CureVac is a biopharmaceutical company that develops and commercializes mRNA-based therapies for the treatment of cancer and infectious diseases.

mRNA therapeutics cancer therapies prophylactic vaccines molecular therapies
Details about CureVac AG
Frequently Asked Questions about Martin Falk
Martin Falk currently works for CureVac.
Martin Falk's role at CureVac is Executive Medical Director, Oncology.
Martin Falk's email address is ***@curevac.com. To view Martin Falk's full email address, please signup to ConnectPlex.
Martin Falk works in the Research industry.
Martin Falk's colleagues at CureVac AG are Paula Muresan, Giorgio Bianchini, Giulia Domenico, Nadine Khattab, Lipika Sahu, Alba Infantes, Miriam Vogel and others.
Martin Falk's phone number is 617-377-4040
See more information about Martin Falk